- Home
- NINE vs IOBT Comparison
NINE vs IOBT Comparison
Compare NINE & IOBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NINE
- IOBT
- Stock Information
- Founded
- NINE 2011
- IOBT 2014
- Country
- NINE United States
- IOBT Denmark
- Employees
- NINE N/A
- IOBT 68
- Industry
- NINE Oilfield Services/Equipment
- IOBT Biotechnology: Pharmaceutical Preparations
- Sector
- NINE Energy
- IOBT Health Care
- Exchange
- NINE Nasdaq
- IOBT Nasdaq
- Market Cap
- NINE 49.6M
- IOBT 57.4M
- IPO Year
- NINE 2018
- IOBT 2021
- Fundamental
- Price
- NINE $1.50
- IOBT $0.87
- Analyst Decision
- NINE
- IOBT Strong Buy
- Analyst Count
- NINE 0
- IOBT 3
- Target Price
- NINE N/A
- IOBT $9.33
- AVG Volume (30 Days)
- NINE 2.1M
- IOBT 203.6K
- Earning Date
- NINE 03-06-2025
- IOBT 03-04-2025
- Dividend Yield
- NINE N/A
- IOBT N/A
- EPS Growth
- NINE N/A
- IOBT N/A
- EPS
- NINE N/A
- IOBT N/A
- Revenue
- NINE $556,751,000.00
- IOBT N/A
- Revenue This Year
- NINE N/A
- IOBT N/A
- Revenue Next Year
- NINE $2.93
- IOBT N/A
- P/E Ratio
- NINE N/A
- IOBT N/A
- Revenue Growth
- NINE N/A
- IOBT N/A
- 52 Week Low
- NINE $0.75
- IOBT $0.66
- 52 Week High
- NINE $3.26
- IOBT $1.89
- Technical
- Relative Strength Index (RSI)
- NINE 62.73
- IOBT 50.48
- Support Level
- NINE $1.13
- IOBT $0.77
- Resistance Level
- NINE $1.35
- IOBT $0.95
- Average True Range (ATR)
- NINE 0.19
- IOBT 0.07
- MACD
- NINE 0.02
- IOBT -0.00
- Stochastic Oscillator
- NINE 68.22
- IOBT 34.43
About NINE Nine Energy Service Inc.
Nine Energy Service Inc is a North American onshore completion and production services provider. It targets unconventional oil and gas resource development. It operates in one segment, Completion Solutions. The Completion Solutions segment offers cementing services; completion tools, including liner hangers and accessories, frac sleeves, fully composite frac plugs, and specialty open hole float equipment and centralizers and other services. It operates in the U.S, Canada, and other countries where majority of the revenue is generated from the United States.
About IOBT IO Biotech Inc.
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.